Showing results (601-610 of 26,310) with videos related to
Sort By:
Pageof 2,631
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Chemical synthesis and cytotoxicity of dihydroxylated cyclopentenone analogues of neocarzinostatin chromophoreMichael D Urbaniak, Lisa M Frost, John P Bingham, et al.Bioorganic & Medicinal Chemistry Letters|June 5, 2003
3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP siteStephen W Wright, Anthony A Carlo, Dennis E Danley, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activityMarcos L Sznaidman, Curt D Haffner, Patrick R Maloney, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2003
A novel metal-chelating inhibitor of protein farnesyltransferaseAkiyuki Hamasaki, Hayato Naka, Fuyuhiko Tamanoi, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Chain-branched acyclic phenethylthiocarbamates as vanilloid receptor antagonistsJungWha Yoon, HyeYoung Choi, Hyun Joo Lee, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Macrocyclic inhibitors of the bacterial cell wall biosynthesis enzyme MurDJames R Horton, Julieanne M Bostock, Ian Chopra, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailabilityYunsong Tong, Nan-Horng Lin, Le Wang, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2003
5-aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)Jason Witherington, Vincent Bordas, David Haigh, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2003
A new model of the tautomycin-PP1 complex that is not analogous to the corresponding okadaic acid structureDavid A Colby, Wen Liu, James E Sheppeck, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbetaMargaret M Faul, James R Gillig, Michael R Jirousek, et al.Pageof 2,631